脳脊髄液管理市場規模・予測（2020年～2030年）、世界・地域シェア、動向、成長機会分析レポート対象範囲製品別（髄液シャント、髄液ドレナージシステム）、エンドユーザー別（病院、診療所、外来手術センター、その他）、地域別

Cerebrospinal Fluid Management Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (CSF Shunts and CSF Drainage Systems), End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others), and Geography

脳脊髄液管理市場の市場規模は、2022年の19億1137万米ドルから2030年には28億9254万米ドルに達すると予想され、2022年から2030年までの年平均成長率は5.3％を記録すると予測されている。より良い治療方法に対... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
The Insight Partners ザ・インサイトパートナーズ	2023年9月6日	US$4,550 シングルユーザライセンスライセンス・価格情報注文方法はこちら	177	英語

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

サマリー

脳脊髄液管理市場の市場規模は、2022年の19億1137万米ドルから2030年には28億9254万米ドルに達すると予想され、2022年から2030年までの年平均成長率は5.3％を記録すると予測されている。

より良い治療方法に対する需要の高まりは、ここ数十年の間に様々な製品開発をもたらした。髄液管理市場における最近の製品開発の例をいくつか以下に挙げる。

- 2022年9月、Anuncia Medical Inc.は水頭症やシャントが必要な他の脳脊髄液障害患者の治療用としてReFlow System Miniの米国食品医薬品局（FDA）承認を取得した。リフロー・システム・ミニは、非侵襲的に脳室カテーテルのフラッシュを促進し、シャント内の髄液流量を回復、増加、維持する。

- 2021年3月、FDAはアヌンシアの髄液管理用ReFlowシステムに画期的医療機器指定を与えた。この装置は、シャントが必要な水頭症などの髄液障害を治療するために設計されている。ReFlowシステムは、非侵襲的に行われる予防的フラッシングのため、在宅ケアやクリニックで使用され、髄液の閉塞を予防する可能性がある。

- 2020年6月、FDAはRhaeos, Inc.が提供するワイヤレス非侵襲フローセンサーFlowSenseにブレークスルーデバイス指定を与えた。この製品は、水頭症による脳脊髄液過多の患者において、脳室シャント機能を迅速にモニターするために設計されている。

神経疾患治療における髄液管理への注目の高まりが脳脊髄液管理市場に新たな機会をもたらす

CSFパラメータは、成人患者における神経疾患のバイオマーカーとして広く評価されている。CSF中の循環マイクロRNAは、さまざまな神経疾患の診断に有望なバイオマーカーです。パーキンソン病（PD）、アルツハイマー病（AD）、てんかん、けいれんなどの神経疾患では、しばしばCSFパラメータが変化する。Nature』誌に掲載された論文によると、PDと診断された患者では、76種類の髄液蛋白質が正常な人と比べて構造的に変化していることが判明した。この研究はまた、これらのCSFタンパク質が疾患の診断や治療のためのバイオマーカーとして使用できることを示唆している。PDは、認知機能障害と運動機能の低下を伴う神経変性疾患である。2022年に発表された世界保健機関（WHO）の報告書によると、PDの有病率は過去25年間で倍増し、60歳以上の世界人口の約1％が罹患している。同様に、発作やてんかんの状態にある患者では、タンパク質や乳酸値のような髄液パラメータのいくつかが変化する。そのため、発作やてんかんの治療に髄液パラメーターを使用するために、さまざまな研究開発が行われている。さらに、CSFを用いたアルツハイマー病検出のためのさまざまなCSFアッセイが市場に出回っているにもかかわらず、検出および治療目的のバイオマーカーに対するニーズは満たされていない。アルツハイマー病やPDの症例検出が増加するにつれて、髄液漏れの症例が増加する可能性があるため、髄液管理デバイスの需要が増加している。したがって、神経疾患の有病率の増加は、これらの疾患の治療に髄液管理製品を使用するための研究開発活動に拍車をかけている。

脳脊髄液管理市場は、製品とエンドユーザーに区分される。製品別では、髄液シャントと髄液ドレナージシステムに二分される。2022年には、CSFシャントセグメントが製品別市場で最大のシェアを占め、同セグメントは、製品発売の増加、高度なCSFシャントに対する需要の増加、水頭症の発生件数の増加により、予測期間中に大きなCAGRで成長すると推定される。髄液シャントはさらに、脳室シャント、脳室心房シャント、脳室胸膜シャント、腰腹膜シャントに区分される。脳脊髄液シャントに基づくと、脳室腹膜シャントが脳脊髄液管理市場で最大の市場シェアを占めており、予測期間中に最も速いCAGRで成長すると予測されている。同様に、髄液ドレナージシステムは、脳室外ドレナージ（EVD）システムと腰椎ドレナージ（LD）システムに分類された。体外式脳室ドレナージシステムは、業界でより一般的に使用されている髄液ドレナージシステムであるため、この分野で最大のシェアを占めている。

地域別に見ると、市場は北米、欧州、アジア太平洋地域中東・アフリカ、南米・中米に区分される。脳脊髄液管理市場では、北米が最大の市場シェアを占めている。水頭症、外傷性脳損傷、その他の神経疾患の発生件数の増加、急速な技術革新、医療インフラの発展により、北米市場は予測期間中も優位を保つと予想される。一方、アジア太平洋地域は、高齢者人口の増加、先進医療機器への需要、効率的な治療を提供する医療インフラの増加などの要因により、同市場で最も急速に成長している地域です。

脳脊髄液管理市場の成長は、髄液漏れの発生件数の増加や髄液管理製品の開発拡大などの主な要因によって規定される。一方、髄液シャントに関連するリスクは市場成長の妨げとなっている。

カナダ感染症レポート（CCDR）、疾病管理予防センター（CDC）、欧州連合（EU）、イタリア貿易庁（ITA）は、脳脊髄液管理市場に関するレポートを作成する際に参照したいくつかの主要な一次情報源および二次情報源です。

ページTOPに戻る

TABLE OF CONTENTS

1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Cerebrospinal Fluid Management Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 South & Central America PEST Analysis
4.2.5 Middle East & Africa PEST Analysis
5. Cerebrospinal Fluid Management Market - Key Industry Dynamics
5.1 Market Drivers
5.1.1 Increasing Incidences of CSF Leak
5.1.2 Growing Developments for CSF Management Products
5.2 Market Restraints
5.2.1 Risk Associated with CSF Shunts
5.3 Market Opportunities
5.3.1 Increasing Focus on Use of CSF Management for Treatment of Neurological Diseases
5.4 Future Trends
5.4.1 Technological Developments for CSF Shunts
5.5 Impact Analysis:
6. Cerebrospinal Fluid Management Market - Global Market Analysis
6.1 Cerebrospinal Fluid Management Market Revenue (US$ Mn), 2022 – 2030
7. Global Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 – by Product
7.1 Overview
7.2 Cerebrospinal Fluid Management Market Revenue Share, by Product 2022 & 2030 (%)
7.3 CSF Shunts
7.3.1 Overview
7.3.2 CSF Shunts: Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
7.3.3 Ventriculoperitoneal Shunts
7.3.3.1 Overview
7.3.3.2 Ventriculoperitoneal Shunts: Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
7.3.4 Ventriculoatrial Shunts
7.3.4.1 Overview
7.3.4.2 Ventriculoatrial Shunts: Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
7.3.5 Ventriculopleural Shunts
7.3.5.1 Overview
7.3.5.2 Ventriculopleural Shunts: Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
7.3.6 Lumboperitoneal Shunts
7.3.6.1 Overview
7.3.6.2 Lumboperitoneal Shunts: Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
7.4 CSF Drainage Systems
7.4.1 Overview
7.4.2 CSF Drainage Systems: Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
7.4.3 External Ventricular Drainage (EVD) Systems
7.4.3.1 Overview
7.4.3.2 External Ventricular Drainage (EVD) Systems: Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
7.4.4 Lumbar Drainage (LD) Systems
7.4.4.1 Overview
7.4.4.2 Lumbar Drainage (LD) Systems: Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
8. Global Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 – by End User
8.1 Overview
8.2 Cerebrospinal Fluid Management Market Revenue Share, by End User 2022 & 2030 (%)
8.3 Hospitals
8.3.1 Overview
8.3.2 Hospitals: Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Clinics
8.4.1 Overview
8.4.2 Clinics: Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Ambulatory Surgical Centers
8.5.1 Overview
8.5.2 Ambulatory Surgical Centers: Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
9. Cerebrospinal Fluid Management Market - Geographical Analysis
9.1 North America Cerebrospinal Fluid Management Market, Revenue and Forecast To 2030
9.1.1 Overview
9.1.2 North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
9.1.2.1 North America Cerebrospinal Fluid Management Market, by Product
9.1.2.1.1 North America Cerebrospinal Fluid Management Market, by CSF Shunts
9.1.2.1.2 North America Cerebrospinal Fluid Management Market, by CSF Drainage Systems
9.1.2.2 North America Cerebrospinal Fluid Management Market, by End User
9.1.2.3 North America Cerebrospinal Fluid Management Market, by Country
9.1.2.4 US
9.1.2.4.1 Overview
9.1.2.4.2 US Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
9.1.2.4.3 US Cerebrospinal Fluid Management Market, by Product
9.1.2.4.3.1 US Cerebrospinal Fluid Management Market, by CSF Shunts
9.1.2.4.3.2 US Cerebrospinal Fluid Management Market, by CSF Drainage Systems
9.1.2.4.4 US Cerebrospinal Fluid Management Market, by End User
9.1.2.5 Canada
9.1.2.5.1 Overview
9.1.2.5.2 Canada Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
9.1.2.5.3 Canada Cerebrospinal Fluid Management Market, by Product
9.1.2.5.3.1 Canada Cerebrospinal Fluid Management Market, by CSF Shunts
9.1.2.5.3.2 Canada Cerebrospinal Fluid Management Market, by CSF Drainage Systems
9.1.2.5.4 Canada Cerebrospinal Fluid Management Market, by End User
9.1.2.6 Mexico
9.1.2.6.1 Overview
9.1.2.6.2 Mexico Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
9.1.2.6.3 Mexico Cerebrospinal Fluid Management Market, by Product
9.1.2.6.3.1 Mexico Cerebrospinal Fluid Management Market, by CSF Shunts
9.1.2.6.3.2 Mexico Cerebrospinal Fluid Management Market, by CSF Drainage Systems
9.1.2.6.4 Mexico Cerebrospinal Fluid Management Market, by End User
9.2 Europe Cerebrospinal Fluid Management Market, Revenue and Forecast to 2030
9.2.1 Overview
9.2.2 Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
9.2.2.1 Europe Cerebrospinal Fluid Management Market, by Product
9.2.2.1.1 Europe Cerebrospinal Fluid Management Market, by CSF Shunts
9.2.2.1.2 Europe Cerebrospinal Fluid Management Market, by CSF Drainage Systems
9.2.2.2 Europe Cerebrospinal Fluid Management Market, by End User
9.2.2.3 Europe Cerebrospinal Fluid Management Market, by Country
9.2.2.4 UK
9.2.2.4.1 Overview
9.2.2.4.2 UK Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
9.2.2.4.3 UK Cerebrospinal Fluid Management Market, by Product
9.2.2.4.3.1 UK Cerebrospinal Fluid Management Market, by CSF Shunts
9.2.2.4.3.2 UK Cerebrospinal Fluid Management Market, by CSF Drainage Systems
9.2.2.4.4 UK Cerebrospinal Fluid Management Market, by End User
9.2.2.5 Germany
9.2.2.5.1 Overview
9.2.2.5.2 Germany Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
9.2.2.5.3 Germany Cerebrospinal Fluid Management Market, by Product
9.2.2.5.3.1 Germany Cerebrospinal Fluid Management Market, by CSF Shunts
9.2.2.5.3.2 Germany Cerebrospinal Fluid Management Market, by CSF Drainage Systems
9.2.2.5.4 Germany Cerebrospinal Fluid Management Market, by End User
9.2.2.6 France
9.2.2.6.1 Overview
9.2.2.6.2 France Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
9.2.2.6.3 France Cerebrospinal Fluid Management Market, by Product
9.2.2.6.3.1 France Cerebrospinal Fluid Management Market, by CSF Shunts
9.2.2.6.3.2 France Cerebrospinal Fluid Management Market, by CSF Drainage Systems
9.2.2.6.4 France Cerebrospinal Fluid Management Market, by End User
9.2.2.7 Italy
9.2.2.7.1 Overview
9.2.2.7.2 Italy Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
9.2.2.7.3 Italy Cerebrospinal Fluid Management Market, by Product
9.2.2.7.3.1 Italy Cerebrospinal Fluid Management Market, by CSF Shunts
9.2.2.7.3.2 Italy Cerebrospinal Fluid Management Market, by CSF Drainage Systems
9.2.2.7.4 Italy Cerebrospinal Fluid Management Market, by End User
9.2.2.8 Spain
9.2.2.8.1 Overview
9.2.2.8.2 Spain Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
9.2.2.8.3 Spain Cerebrospinal Fluid Management Market, by Product
9.2.2.8.3.1 Spain Cerebrospinal Fluid Management Market, by CSF Shunts
9.2.2.8.3.2 Spain Cerebrospinal Fluid Management Market, by CSF Drainage Systems
9.2.2.8.4 Spain Cerebrospinal Fluid Management Market, by End User
9.2.2.9 Rest of Europe
9.2.2.9.1 Overview
9.2.2.9.2 Rest of Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
9.2.2.9.3 Rest of Europe Cerebrospinal Fluid Management Market, by Product
9.2.2.9.3.1 Rest of Europe Cerebrospinal Fluid Management Market, by CSF Shunts
9.2.2.9.3.2 Rest of Europe Cerebrospinal Fluid Management Market, by CSF Drainage Systems
9.2.2.9.4 Rest of Europe Cerebrospinal Fluid Management Market, by End User
9.3 Asia Pacific Cerebrospinal Fluid Management Market, Revenue and Forecast to 2030
9.3.1 Overview
9.3.2 Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
9.3.2.1 Asia Pacific Cerebrospinal Fluid Management Market, by Product
9.3.2.1.1 Asia Pacific Cerebrospinal Fluid Management Market, by CSF Shunts
9.3.2.1.2 Asia Pacific Cerebrospinal Fluid Management Market, by CSF Drainage Systems
9.3.2.2 Asia Pacific Cerebrospinal Fluid Management Market, by End User
9.3.2.3 Asia Pacific Cerebrospinal Fluid Management Market, by Country
9.3.2.4 China
9.3.2.4.1 Overview
9.3.2.4.2 China Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
9.3.2.4.3 China Cerebrospinal Fluid Management Market, by Product
9.3.2.4.3.1 China Cerebrospinal Fluid Management Market, by CSF Shunts
9.3.2.4.3.2 China Cerebrospinal Fluid Management Market, by CSF Drainage Systems
9.3.2.4.4 China Cerebrospinal Fluid Management Market, by End User
9.3.2.5 Japan
9.3.2.5.1 Overview
9.3.2.5.2 Japan Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
9.3.2.5.3 Japan Cerebrospinal Fluid Management Market, by Product
9.3.2.5.3.1 Japan Cerebrospinal Fluid Management Market, by CSF Shunts
9.3.2.5.3.2 Japan Cerebrospinal Fluid Management Market, by CSF Drainage Systems
9.3.2.5.4 Japan Cerebrospinal Fluid Management Market, by End User
9.3.2.6 India
9.3.2.6.1 Overview
9.3.2.6.2 India Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
9.3.2.6.3 India Cerebrospinal Fluid Management Market, by Product
9.3.2.6.3.1 India Cerebrospinal Fluid Management Market, by CSF Shunts
9.3.2.6.3.2 India Cerebrospinal Fluid Management Market, by CSF Drainage Systems
9.3.2.6.4 India Cerebrospinal Fluid Management Market, by End User
9.3.2.7 Australia
9.3.2.7.1 Overview
9.3.2.7.2 Australia Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
9.3.2.7.3 Australia Cerebrospinal Fluid Management Market, by Product
9.3.2.7.3.1 Australia Cerebrospinal Fluid Management Market, by CSF Shunts
9.3.2.7.3.2 Australia Cerebrospinal Fluid Management Market, by CSF Drainage Systems
9.3.2.7.4 Australia Cerebrospinal Fluid Management Market, by End User
9.3.2.8 South Korea
9.3.2.8.1 Overview
9.3.2.8.2 South Korea Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
9.3.2.8.3 South Korea Cerebrospinal Fluid Management Market, by Product
9.3.2.8.3.1 South Korea Cerebrospinal Fluid Management Market, by CSF Shunts
9.3.2.8.3.2 South Korea Cerebrospinal Fluid Management Market, by CSF Drainage Systems
9.3.2.8.4 South Korea Cerebrospinal Fluid Management Market, by End User
9.3.2.9 Rest of Asia Pacific
9.3.2.9.1 Overview
9.3.2.9.2 Rest of Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
9.3.2.9.3 Rest of Asia Pacific Cerebrospinal Fluid Management Market, by Product
9.3.2.9.3.1 Rest of Asia Pacific Cerebrospinal Fluid Management Market, by CSF Shunts
9.3.2.9.3.2 Rest of Asia Pacific Cerebrospinal Fluid Management Market, by CSF Drainage Systems
9.3.2.9.4 Rest of Asia Pacific Cerebrospinal Fluid Management Market, by End User
9.4 Middle East & Africa Cerebrospinal Fluid Management Market, Revenue and Forecast to 2030
9.4.1 Overview
9.4.2 Middle East & Africa Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
9.4.2.1 Middle East & Africa Cerebrospinal Fluid Management Market, by Product
9.4.2.1.1 Middle East & Africa Cerebrospinal Fluid Management Market, by CSF Shunts
9.4.2.1.2 Middle East & Africa Cerebrospinal Fluid Management Market, by CSF Drainage Systems
9.4.2.2 Middle East & Africa Cerebrospinal Fluid Management Market, by End User
9.4.2.3 Middle East & Africa Cerebrospinal Fluid Management Market, by Country
9.4.2.4 UAE
9.4.2.4.1 Overview
9.4.2.4.2 UAE Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
9.4.2.4.3 UAE Cerebrospinal Fluid Management Market, by Product
9.4.2.4.3.1 UAE Cerebrospinal Fluid Management Market, by CSF Shunts
9.4.2.4.3.2 UAE Cerebrospinal Fluid Management Market, by CSF Drainage Systems
9.4.2.4.4 UAE Cerebrospinal Fluid Management Market, by End User
9.4.2.5 Saudi Arabia
9.4.2.5.1 Overview
9.4.2.5.2 Saudi Arabia Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
9.4.2.5.3 Saudi Arabia Cerebrospinal Fluid Management Market, by Product
9.4.2.5.3.1 Saudi Arabia Cerebrospinal Fluid Management Market, by CSF Shunts
9.4.2.5.3.2 Saudi Arabia Cerebrospinal Fluid Management Market, by CSF Drainage Systems
9.4.2.5.4 Saudi Arabia Cerebrospinal Fluid Management Market, by End User
9.4.2.6 South Africa
9.4.2.6.1 Overview
9.4.2.6.2 South Africa Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
9.4.2.6.3 South Africa Cerebrospinal Fluid Management Market, by Product
9.4.2.6.3.1 South Africa Cerebrospinal Fluid Management Market, by CSF Shunts
9.4.2.6.3.2 South Africa Cerebrospinal Fluid Management Market, by CSF Drainage Systems
9.4.2.6.4 South Africa Cerebrospinal Fluid Management Market, by End User
9.4.2.7 Rest of Middle East & Africa
9.4.2.7.1 Overview
9.4.2.7.2 Rest of Middle East & Africa Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
9.4.2.7.3 Rest of Middle East & Africa Cerebrospinal Fluid Management Market, by Product
9.4.2.7.3.1 Rest of Middle East & Africa Cerebrospinal Fluid Management Market, by CSF Shunts
9.4.2.7.3.2 Rest of Middle East & Africa Cerebrospinal Fluid Management Market, by CSF Drainage Systems
9.4.2.7.4 Rest of Middle East & Africa Cerebrospinal Fluid Management Market, by End User
9.5 South & Central America Cerebrospinal Fluid Management Market, Revenue and Forecast to 2030
9.5.1 Overview
9.5.2 South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
9.5.2.1 South & Central America Cerebrospinal Fluid Management Market, by Product
9.5.2.1.1 South & Central America Cerebrospinal Fluid Management Market, by CSF Shunts
9.5.2.1.2 South & Central America Cerebrospinal Fluid Management Market, by CSF Drainage Systems
9.5.2.2 South & Central America Cerebrospinal Fluid Management Market, by End User
9.5.2.3 South & Central America Cerebrospinal Fluid Management Market, by Country
9.5.2.4 Brazil
9.5.2.4.1 Overview
9.5.2.4.2 Brazil Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
9.5.2.4.3 Brazil Cerebrospinal Fluid Management Market, by Product
9.5.2.4.3.1 Brazil Cerebrospinal Fluid Management Market, by CSF Shunts
9.5.2.4.3.2 Brazil Cerebrospinal Fluid Management Market, by CSF Drainage Systems
9.5.2.4.4 Brazil Cerebrospinal Fluid Management Market, by End User
9.5.2.5 Argentina
9.5.2.5.1 Overview
9.5.2.5.2 Argentina Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
9.5.2.5.3 Argentina Cerebrospinal Fluid Management Market, by Product
9.5.2.5.3.1 Argentina Cerebrospinal Fluid Management Market, by CSF Shunts
9.5.2.5.3.2 Argentina Cerebrospinal Fluid Management Market, by CSF Drainage Systems
9.5.2.5.4 Argentina Cerebrospinal Fluid Management Market, by End User
9.5.2.6 Rest of South & Central America
9.5.2.6.1 Overview
9.5.2.6.2 Rest of South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
9.5.2.6.3 Rest of South & Central America Cerebrospinal Fluid Management Market, by Product
9.5.2.6.3.1 Rest of South & Central America Cerebrospinal Fluid Management Market, by CSF Shunts
9.5.2.6.3.2 Rest of South & Central America Cerebrospinal Fluid Management Market, by CSF Drainage Systems
9.5.2.6.4 Rest of South & Central America Cerebrospinal Fluid Management Market, by End User
10. Pre & Post Covid-19 Impact
10.1 Pre & Post Covid-19 Impact
11. Cerebrospinal Fluid Management Market –Industry Landscape
11.1 Overview
11.2 Growth Strategies in The Cerebrospinal Fluid Management Market, 2020-2023
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Medtronic Plc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Integra LifeSciences Holdings Corp
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 B. Braun SE
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Argi Group Health Services Ltd Sti
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Sophysa SA
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 BeckerSmith Medical Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Delta Surgical Ltd
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Moller Medical GmbH
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Natus Medical Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Spiegelberg GmbH & Co KG
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms

ページTOPに戻る

Table of Contents

Summary

The cerebrospinal fluid management market size is expected to reach US$ 2,892.54 million by 2030 from US$ 1,911.37 million in 2022; it is estimated to record a CAGR of 5.3% from 2022 to 2030.

The growing demand for better treatment modalities has resulted in various product developments in the last few decades. A few of the examples of recent product developments in the CSF management market are mentioned below.

• In September 2022, Anuncia Medical Inc received US Food and Drug Administration (FDA) approval for its ReFlow System Mini for the treatment of patients with hydrocephalus and other cerebrospinal fluid disorders that require shunting. ReFlow System Mini noninvasively facilitates a flush of ventricular catheters to restore, increase, or maintain CSF flow in a shunt.

• In March 2021, the FDA granted a breakthrough device designation for the ReFlow System of Anuncia for CSF management. The device is designed to treat CSF disorders such as hydrocephalus, which require shunting. ReFlow system can be used in homecare settings and in clinics for prophylactic flushing that is performed noninvasively to potentially prevent CSF blockages.

• In June 2020, the FDA granted Breakthrough Device Designation to the FlowSense wireless, noninvasive flow sensor offered by Rhaeos, Inc. The product is designed to rapidly monitor ventricular shunt function in patients with excess cerebrospinal fluid caused by hydrocephalus.

Increasing Focus on CSF Management in Neurological Disease Treatments Provides New Opportunities for the Cerebrospinal Fluid Management Market

CSF parameters are extensively evaluated as biomarkers of neurological disorders in adult patients. Circulating microRNAs in CSF are a promising class of biomarkers for the diagnosis of various neurological diseases. Neurological disorders such as Parkinson’s Disease (PD), Alzheimer’s Disease (AD), epilepsy, and seizures often lead to altered CSF parameters. According to an article published in Nature, 76 CSF proteins were found to be structurally altered in patients that were diagnosed with PD when compared to normal individuals. The study also suggests that these CSF proteins can be used as biomarkers for the diagnosis or treatment of the disease. PD is a neurodegenerative disease associated with loss of cognitive impairment and motor function. According to the World Health Organization (WHO) report published in 2022, the prevalence of PD has doubled in the last 25 years, affecting ~1% of the global population aged more than 60 years. Similarly, a few of the CSF parameters such as protein and lactate levels are altered in patients suffering from seizure or status epilepticus. Therefore, various R&D activities are going on for using CSF parameters in the treatment of seizures or epilepsy. Further, despite the availability of various CSF assays for the detection of Alzheimer’s disease using CSF in the market, there are unmet needs for biomarkers for detection and treatment purposes. As the detection of cases of Alzheimer’s disease and PD increases, there is increase in demand for CSF management devices as the cases of CSF leaks may increases. Therefore, a rise in the prevalence of neurological disorders is fueling the research and development activities for the use of CSF management products in the treatment of these disorders.

The cerebrospinal fluid management market is segments into product and end user. Based on product, the market is bifurcated into CSF shunts and CSF drainage systems. In 2022, the CSF shunts segment held the largest share of the market by product. and the same segment is estimated to grow at a significant CAGR during the forecast period due to growing product launches, increasing demand for advanced CSF shunts, and increasing incidences of hydrocephalus. CSF shunts was further segmented into ventriculoperitoneal shunts, ventriculoatrial shunts, ventriculopleural shunts, and lumboperitoneal shunts. Based on CSF shunts, ventriculoperitoneal shunts held the largest market share of cerebrospinal fluid management market and is expected to grow at a fastest CAGR during the forecast period. Similarly, the CSF drainage systems were classified into external ventricular drainage (EVD) systems and lumbar drainage (LD) systems. External ventricular drainage systems are the more commonly used CSF drainage systems in the industry therefore, marking largest share of the segment.

Based on geography, the market is segmented into North America, Europe, Asia Pacific Middle East & Africa, and South & Central America. North America held the largest market share of the cerebrospinal fluid management market. The market in North America is expected to continue its dominance during the forecast period due to the increasing hydrocephalus, traumatic brain injury, and other neurological condition incidences; rapid technological innovations; and developing healthcare infrastructure. Whereas Asia Pacific is the fastest growing region in the market owing to the factors, including growing geriatric population, demand for advanced medical devices, and increasing healthcare infrastructures offering efficient treatments.

The growth of cerebrospinal fluid management market is defined by some of the key factors, such as increasing incidences of CSF leak and growing developments for CSF management products. On the other hand, the risk associated with CSF shunts hinders the market growth.

The Canada Communicable Disease Report (CCDR), Centers for Disease Control and Prevention (CDC), European Union, Italian Trade Agency (ITA) are a few key primary and secondary sources referred to while preparing the report on the cerebrospinal fluid management market.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療機器）の最新刊レポート

The Insight Partners社の医療機器分野での最新刊レポート

本レポートと同じKEY WORD（clinics）の最新刊レポート

よくあるご質問

The Insight Partners社はどのような調査会社ですか?

The Insight Partnersはインドに本社を置く調査会社です。経験豊富な専門家チームを通じて、お客様に最適な調査と分析を提供することに専念しています。幅広い分野をカバーしていますがヘルスケ... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（医療機器）の最新刊レポート

The Insight Partners社の医療機器分野での最新刊レポート

本レポートと同じKEY WORD（clinics）の最新刊レポート

よくあるご質問

The Insight Partners社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?